SCHEMBL21031304

SCHEMBL21031304

c1ccc(-c2ccc(-c3cc(-c4c5ccccc5nc5oc6ccccc6c45)nc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.42
▸ KMT2A Q03164 7/20 0.42
▸ HPGD P15428 6/20 0.42
▸ ALDH1A1 P00352 5/20 0.42
▸ MAPT P10636 5/20 0.42
▸ NTSR1 P30989 1/20 0.42
▸ DHODH Q02127 1/20 0.40
▸ LMNA P02545 4/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ ACHE P22303 1/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ GLA P06280 1/20 0.38
▸ ADORA2A P29274 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.36
▸ ACACA Q13085 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21031303 0.97 MEN1 (0.41) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21031310 0.95 HPGD (0.42) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21031309 0.95 HPGD (0.42) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21031251 0.94 HPGD (0.43) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL25847800 0.93 MEN1 (0.36) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21030663 0.92 DHODH (0.42) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21031471 0.92 HPGD (0.41) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21030667 0.91 HPGD (0.40) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21032445 0.91 HPGD (0.40) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21031474 0.90 HPGD (0.39) MEN1KMT2AHPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885HPGD 2093/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885HPGD 2093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback